Latest Blogs

Jun 20, 2019
Key cancer-related topics discussed at the AMA-HOD meeting included alcohol ingestion as a causation risk factor, appropriate guidelines for opioids in the cancer setting, and the use of de-identified patient information.
Jun 19, 2019
"We believe what mattered the most about #ASCO19 is that patients were part of the discussion," write Dr. Mark A. Lewis and Dr. Chadi Nabhan.
Jun 11, 2019
I am excited about the entire Breakthrough program, including a session I am leading on the impact of social media and telehealth on cancer care.
Jun 11, 2019
Real actions that promote women and under-represented groups in medicine are doable, starting today.
Subscribe to this column

Don S. Dizon, MD, FACP, FASCO

Don S. Dizon, MD, FACP, FASCO, is head of Women's Cancers at Lifespan Cancer Institute, director of Medical Oncology at Rhode Island Hospital, and a professor of medicine at The Warren Alpert Medical School of Brown University. Dr. Dizon serves as chair of ASCO's Social Media Working Group and is a past chair of the Cancer Communications Committee. In addition to his regular column on ASCOconnection.org, which has been honored with APEX awards in 2013 and 2014, he is a blogger for The Oncologist and a section editor of Gynecologic Oncology at UpToDate. Dr. Dizon is a member of the Journal of Clinical Oncology Editorial Board, and editor in chief of the ASCO Educational BookFollow Dr. Dizon on Twitter @drdonsdizon.

Dec 11, 2018
What do you do when a patient requests a different physician, and you suspect prejudice is the reason?
Nov 20, 2018
 Although there are still several weeks left in 2018, events have left me speechless twice this year: the deaths of two women, well before their time.
Oct 30, 2018
How using the term "screen failure" can be a disservice to clinical trial teams and patients alike. 
Sep 25, 2018
To be a truly good doctor, you can't just care for people - you have to care about people.
Sep 11, 2018
I had the enormous privilege of speaking with poet Anya Silver about her experience living with metastatic breast cancer and her perspective on physician-patient communication.
Jul 31, 2018
A precision therapy was indicated and available for my patient, but we lost the window of opportunity to administer it safely.

Pages